Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)

Por Tsai, J. N., Uihlein, A. V., Burnett-Bowie, S. M., Neer, R. M., Derrico, N. P., Lee, H., Bouxsein, M. L., Leder, B. Z.
Publicado no J Clin Endocrinol Metab (2016)

Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial

Por Bilezikian, J. P., Hattersley, G., Fitzpatrick, L. A., Harris, A. G., Shevroja, E., Banks, K., Leder, B. Z., Zanchetta, J. R., Hans, D.
Publicado no Osteoporos Int (2017)